Earnings Call · Q1 FY2023·2025-10-06

Q1 23EPS n/a·Rev n/aQ4 22EPS n/a·Rev n/aQ3 22EPS n/a·Rev n/aQ2 22EPS n/a·Rev n/a⚠ consensus missing

Skye Bioscience, Inc. SKYE

Bernie Hertel — Head of Investor Relations

Punit Dhillon — Chief Executive Officer

Puneet Arora — Chief Medical Officer

Tu Diep — Unknown

Christopher Twitty — Chief Scientific Officer

−60.0%1d on move date−60.4% vs SPY3d−63.8%5d−63.6%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more SKYE calls or request research access.

More SKYE calls Browse calls Request research access